From these studies it can be concluded that Ca2+ entry through TRPC6 and TRPV4 contributes to the growth and progression of HCC, while activation of TRPV1 may be targeted to kill HCC cells. This evidence concerns the gene TRPV4 and hepatocellular carcinoma.